Cariprazine: Patients with Treatment-Resistant Schizophrenia

by Aubel T
Published 2021-07-01

Treatment resistant schizophrenia in Slovenian population

by Tea Terzić, Vita Dolžan, Matej Kastelic, Blanka Kores Plesničar
Published 2014-10-01

Recovery in People with Schizophrenia (PwS)

by Arum Septi Mawarni, Zainal Abidin, Ahmad Gimmy Prathama Siswadi
Published 2019-12-01

Neurological soft signs in psychoses. II: an explorative study of structural involvement amongst drug naive first episode patients

by Pranjal Sharma, Kamal Nath
Published 2016-01-01

Cognitive functions in schizophrenia: a comparative study in an Indian population

by Kaberi Bhattacharyya, Prathama Guha, Malay Ghosal, Prabir Barman
Published 2012-06-01

Cognition and neuroimaging in schizophrenia

by Vince D Calhoun, Vince D Calhoun, Kenneth eHugdahl, Kenneth eHugdahl, Kenneth eHugdahl
Published 2012-10-01

Perception regarding the causes of schizophrenia and associated factors among Feresbet district residents: a community based study

by Zelalem Belayneh, Dessie Abebaw, Tadele Amare, Kibrom Haile, Zegeye Abebe
Published 2019-03-01

Is disorganized schizophrenia a predictor of treatment resistance? Evidence from an observational study

by Bruno Bertolucci Ortiz, Gerardo Maria de Araújo Filho, Ary Gadelha de Alencar Araripe Neto, Daiane Medeiros, Rodrigo Affonseca Bressan
Published 2013-12-01

Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia

by Yan-Bing Xiong, Yan-Bing Xiong, Yan-Bing Xiong, Yan-Bing Xiong, Qi-Jing Bo, Qi-Jing Bo, Qi-Jing Bo, Qi-Jing Bo, Chang-Ming Wang, Chang-Ming Wang, Chang-Ming Wang, Chang-Ming Wang, Qing Tian, Qing Tian, Qing Tian, Qing Tian, Yi Liu, Yi Liu, Yi Liu, Yi Liu, Chuan-Yue Wang, Chuan-Yue Wang, Chuan-Yue Wang, Chuan-Yue Wang
Published 2019-03-01

The Impact of Spirituality and Spiritually-Oriented Therapeutic Interventions on Schizophrenia Patients

by Özge Erduran
Published 2019-10-01

An editorial on cognition across the psychiatric disorder spectrum: How can schizotypy inform us?

by Caroline eGurvich, Susan L Rossell, Susan L Rossell
Published 2015-08-01

Theories of the pathogenesis of schizophrenia

by Justyna Dąbrowska, Magdalena Wójcik, Julita Szarpak, Damian Bator, Joanna Milanowska, Hubert Nieścior
Published 2020-08-01

Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations

by Amber N. Edinoff, Juliana M. Fort, Joshua J. Woo, Christopher D. Causey, Caroline R. Burroughs, Elyse M. Cornett, Adam M. Kaye, Alan D. Kaye
Published 2021-09-01

Stochastic Model-Informed Cognitive Neuroscience of Stroop-Performance in Schizophrenia

by Reggie Taylor, Reggie Taylor, Jean Théberge, Jean Théberge, Jean Théberge, Peter C Williamson, Peter C Williamson, Peter C Williamson, Maria Densmore, Maria Densmore, Richard James Neufeld, Richard James Neufeld, Richard James Neufeld
Published 2016-09-01

Effective and underprescribed: what about clozapine?

by Helge H.O. Müller
Published 2017-10-01

Mortality among patients with non-affective functional psychoses in a metropolitan area of South-Eastern Brazil

by Paulo R. Menezes, Anthony H. Mann

Comparison of Memory Deficit in Paranoid & Residual Schizophrenic patients with Normal Subjects

by Mahnaz Mehrabizadeh Honarmand, Bahman Najarian, Nahid Ansarian
Published 2003-11-01

Cannabis use and abuse correlates in a homogenous South African schizophrenia population

by Liezl Koen, Regan Jonathan, Dana JH Niehaus
Published 2009-03-01

A report from XIX Schizophrenia Forum Conference in Warsaw

by Dziwota Ewelina, Dziwota Kamila, Olajossy Marcin
Published 2016-06-01

Schizophrenia as a process of mental dissolution

by Perzyńska-Starkiewicz Aneta
Published 2018-09-01